Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) for central nervous system (CNS) disorders. It serves as a chiral building block in the production of selective enzyme inhibitors and receptor modulators. Commonly employed in the manufacture of antipsychotic and antidepressant drugs due to its structural similarity to known neuroactive compounds. Also utilized in research settings for the development of novel pyrrolidine-based bioactive molecules.